Learn first-hand how Ypsomed leveraged the Viable System Model (VSM) as a reference framework for a profound organizational transformation.
In this webinar, Michael Zaugg, Head of Corporate Services at Ypsomed, and Christoph Mahr, consultant and advisor for the VSM implementation, share their experiences with this successful transformation. They will explain why the executive team chose VSM, how the implementation was carried out, and what challenges had to be overcome.
Key topics of the webinar:
· Why VSM was chosen as the model for organizational development
· How the implementation was structured in practice
· Challenges, success factors and key learnings
· Practical recommendations for leaders driving transformation processes
Gain valuable insights from experts and get inspired to shape the future of your organization in a sustainable way!
Ypsomed: Company Overview
Ypsomed is a leading Swiss medical technology company specializing in the development and manufacturing of injection and infusion systems for self-medication. Under the mylife Diabetescare brand, the company also offers a comprehensive portfolio of products and services for people with diabetes.
Founded in 1984 by brothers Willy and Peter Michel under the name Disetronic, Ypsomed has over 40 years of industry experience. Today, the company is headquartered in Burgdorf, Switzerland, and employs around 2,600 people worldwide.
Ypsomed is recognized for its innovative strength and was recently named Switzerland’s most innovative company in a survey conducted by BILANZ and Statista.